Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis

• 主要な著者: Miho Takemura (著者), Kenji Ikemura (著者), Masayoshi Kondo (著者), Fumihiro Yamane (著者), Mikiko Ueda (著者), Masahiro Okuda (著者)
• フォーマット: 図書
• 出版事項: BMC, 2022-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Cisplatin (CDDP)-induced nephrotoxicity is the most important complication of CDDP treatment. 5-Hydroxytryptamine type 3 receptor antagonists (5-HT3RAs) are widely used to prevent chemotherapy-induced nausea and vomiting (CINV). However, in patients with the triple antiemetic (ne...